Universal Health ServicesFRA:UHS +3.25%77 EBITDA Margin % is 14.69% as of Mar. 2026, which is 3% below its 10-year median of 15.15. GuruFocus rates FRA:UHS with a GF Score™ of 77/100 and a GF Value™ of €192.47 (Significantly Undervalued). Among 668 Healthcare Providers & Services companies, Universal Health Services ranks better than 63.77% on this metric.
Universal Health Services (FRA:UHS) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Universal Health Services EBITDA Margin % Related Terms
Universal Health Services EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:UHS vs ENSG, EHC, PACS: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Universal Health Services's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Universal Health Services EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Universal Health Services's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Universal Health Services's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Universal Health Services (FRA:UHS) has a EBITDA Margin % of 14.69% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Universal Health Services and its competitors. This is near median its historical median of 15.15. Over the past decade, Universal Health Services' EBITDA Margin % has ranged from 11.75 to 17.22. According to the industry distribution chart, Universal Health Services ranks #242 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 36.2%.
Is Universal Health Services' EBITDA Margin % too high?
Universal Health Services' current EBITDA Margin % of 14.69% is near median its 10-year median of 15.15. Over the past 10 years, this metric has ranged from a low of 11.75 to a high of 17.22. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Universal Health Services' value of 14.69% is 43.9% above this industry median. Based on the distribution chart, Universal Health Services ranks #242 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Universal Health Services has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Universal Health Services' EBITDA Margin % compare to ENSG and EHC?
According to the Healthcare Providers & Services industry distribution chart, Universal Health Services ranks #242 out of 668 companies for EBITDA Margin %. This puts Universal Health Services in the upper half of its industry. The industry median EBITDA Margin % is 10.21. Universal Health Services' value of 14.69% is 43.9% above this benchmark. Historically, Universal Health Services' own EBITDA Margin % has ranged from 11.75 to 17.22 over the past decade. While the company's 10-year median is 15.15 vs. the industry median of 10.21, Universal Health Services has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Universal Health Services's current EBITDA Margin % of 14.69% is 43.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Universal Health Services and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Universal Health Services's current EBITDA Margin % is 14.69%, which is near median its own 10-year median of 15.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universal Health Services stock overvalued right now?
Based on GuruFocus' analysis, Universal Health Services (FRA:UHS) is currently considered Significantly Undervalued. The stock's GF Value™ is €192.47, compared to a current price of €127.00 — trading 34% below its estimated fair value. The current EBITDA Margin % is 14.69%, which is near median its 10-year median of 15.15 and 43.9% above the Healthcare Providers & Services industry median of 10.21. Universal Health Services' overall GF Score™ is 77/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Universal Health Services (FRA:UHS), the current EBITDA Margin % is 14.69% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Universal Health Services (FRA:UHS) Overvalued in 2026?
Based on GuruFocus' analysis, Universal Health Services stock appears to be undervalued.
The current stock price of €127.00 is trading 34% below its estimated GF Value™ of €192.47.
GuruFocus considers Universal Health Services to be Significantly Undervalued.
Key valuation signals for FRA:UHS:
EBITDA Margin %: 14.69% (near median its 10-year median of 15.15)
GF Value™: €192.47 vs. price of €127.00 (34% below fair value)
Industry Position: 43.9% above the Healthcare Providers & Services median (#242 of 668)
No single metric tells the full story. See the FRA:UHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Universal Health Services Inc offers healthcare services through its behavioral health centers, acute care hospitals, and related outpatient facilities. As of late 2025, the company operated 346 inpatient behavioral health centers, 29 acute care hospitals, and many supportive outpatient facilities. Its operations are concentrated in the U.S, particularly in Nevada (21% of 2025 operating profits), Texas (19%), and California (13%), although it does have some exposure to the UK behavioral health market (6% of 2025 sales) too. While its acute care services account for over 55% of revenue, the behavioral health centers sport higher margins and account for over 55% of pretax profits.
77GF Score
Get the complete analysis for FRA:UHS
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:UHS has been successfully added to your 
